Unresectable Gastroesophageal Junction Adenocarcinoma Recruiting Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0113409 (Unresectable Gastroesophageal Junction Adenocarcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04391049Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for SurgeryTreatment